iSpecimen Inc. Common Stock (ISPC) Stock Price
ISPCStock
$1.54−94.65%52W
Market Cap$3.88M
P/E—
PEG Ratio—
Div yield—
Beta1.66
ISPC Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-96.95%
Price vs S&P 500 (4W)-24.92%
VGM Score13.62
ISPC Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2024 | -$224.00 | -$152.00 | +32.14%(+$72.00) | |
| Q1 2024 | -$216.00 | -$256.00 | -18.52%(-$40.00) | |
| Q4 2023 | -$192.00 | -$272.00 | -41.67%(-$80.00) | |
| Q3 2023 | -$280.00 | -$184.00 | +34.29%(+$96.00) |
ISPC Analyst Recommendations
Sep 2024
Oct 2024
Nov 2024
Dec 2024
4.14
4.14
4.14
4.14
Industry Peers — R&D — Physical Sciences(16)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ISPCiSpecimen Inc. Common Stock | D | F | F | $1.54 |
| IQVIQVIA Holdings Inc. | D | C | A | $261.75 |
| INCYIncyte Genomics Inc | C | A | B | $124.37 |
| MEDPMedpace Holdings, Inc. Common Stock | F | B | B | $600.65 |
| CRLCharles River Laboratories International, Inc. | D | D | B | $291.50 |
| ICLRIcon Plc | C | C | B | $170.02 |
| ABSIAbsci Corporation Common Stock | F | F | A | $8.71 |
| OABIOmniAb, Inc. Common Stock | D | C | A | $4.47 |
| NRCNRC Health Common Stock | D | D | B | $21.85 |
| MXCTMaxCyte, Inc. Common Stock | C | D | C | $1.22 |
| IBACIB Acquisition Corp. Common Stock | — | D | C | $10.89 |
About iSpecimen Inc. Common Stock
iSpecimen Inc is a technology-enabled biospecimen supplier that connects life science researchers and pharmaceutical companies with human tissues, fluids, and stem cells. The company procures specimens from hospitals, laboratories, and medical facilities globally, with operations primarily concentrated in the Americas. iSpecimen enables drug development and clinical research by providing researchers access to the biosamples necessary for their studies.